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Abstract: The menopausal transition is a critical period in women’s lives. Exercise might be 
the most promising non-pharmaceutic intervention to address the large variety of risk factors 
related to the pronounced estradiol decline during peri- and early-postmenopause. The aim of 
this study was to determine the effect of an 18-month multipurpose exercise program on risk 
factors and symptoms related to the menopausal transition. Fifty-four women 1–5 years 
postmenopause with osteopenia or osteoporosis were randomly assigned 1) to a high impact 
weight-bearing/high-intensity/velocity resistance training group (EG: n=27) exercising three 
times a week or 2) to an attendance control group (CG: n=27) that performed low-intensity 
exercise once a week. Both groups were supplemented with cholecalciferol and calcium. The 
primary study endpoint was bone mineral density (BMD) at lumbar spine (LS) and total hip, 
secondary outcomes were lean body mass (LBM), total and abdominal body percentage, 
metabolic syndrome Z-Score (MetS-Z), menopausal symptoms and muscle strength and 
power. Due to COVID-19, the study was stopped after 13 months. We observed significant 
effects for BMD-LS (EG: 0.002±.018 versus CG: −.009±0.018 mg/cm2, p=0.027) but not for 
BMD total hip (EG: −0.01±.016 versus CG: −.009±0.020 mg/cm2, p=0.129). LBM improved 
significantly in the EG and decreased in the CG (0.39±1.08 vs −0.37±1.34 kg, p=0.026). 
Total and abdominal body fat improved significantly in the EG and was maintained in the CG 
(−1.44±1.49 vs −0.02±1.55 kg, p=0.002 and -1.50±2.33 vs 0.08±2.07 kg, p=0.011). 
Significant effects in favor of the EG were also determined for menopausal symptoms 
(p=0.029), hip/leg extension strength (p<0.001) and power (p<0.001). However, changes 
of the MetS-Z did not differ significantly (p=0.149) between EG and CG. In summary, with 
minor exceptions, we demonstrated the effectiveness of a multipurpose exercise protocol 
dedicated to early-postmenopausal women on various risk factors and complaints related to 
the menopausal transition. 
Keywords: multipurpose exercise, bone mineral density, early postmenopause
Introduction
The consequences of the menopausal transition considerably affect women’s lives. 
In addition to the psychosocial effects,1 the pronounced perimenopausal/early 
postmenopausal decline of estradiol (E2)2,3 frequently initiates clinical changes 
including accelerated bone loss,4 changes in body composition,5,6 functional 
declines7,8 and/or menopausal symptoms.9 Exercise might be the most promising 
non-pharmaceutic intervention10–13 to address the variety of (early) menopausal 
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risk factors and complaints.13–16 However, considering 
that exercise protocols are in general specifically aligned 
to one outcome or condition, the challenge of designing 
comprehensive exercise programs for (early-) menopausal 
women is obvious. We addressed the issue of designing 
a multipurpose exercise protocol for early-menopausal 
women in two earlier exercise studies;17,18 however, in 
the present ACTLIFE (Physical ACTivity: the tool to 
improve the quality of LIFE in osteoporosis people) 
study we additionally (1) set out to condense the exercise 
program to reduce the time demand and (2) particularly 
focused on relatively young women with osteopenia and 
osteoporosis who were not eligible for pharmacologic 
therapy due to their young age. The time-effective high- 
intensity endurance and resistance exercise approach spe-
cifically dedicated to women in their early fifties might be 
considered as the unique selling point of the ACTLIFE 
study. Correspondingly, the aim of ACTLIFE was to deter-
mine the effect of an 18-month multipurpose exercise 
program on risk factors and symptoms related to the 
menopausal transition, with specific regard to changes 
in BMD.
The primary hypothesis was that the exercise group 
(EG) of early postmenopausal women with osteopenia 
and osteoporosis would show significantly higher effects 
on a) BMD at the LS and b) total hip compared with an 
attention control group (CG).
Secondary hypotheses were that the EG would show 
significantly higher effects on a) soft (bone free) lean body 
mass, b) total and c) abdominal body fat, d) cardiometa-
bolic risk, e) menopausal symptoms and f) physical fitness 
compared with an attention CG.
Methods
The present work is part of the ACTLIFE project, 
a European Project that focuses on the development and 
dissemination of best practice exercise protocols for sec-
ondary and tertiary prevention of osteoporosis. The 
ACTLIFE consortium is comprised of scientific partner 
institutions from Bulgaria, Finland, Germany, Ireland and 
the UK, headed by the University of Bologna, Italy. The 
present study aimed to validate exercise recommendations 
derived from national guidelines and meta-analyses16 in 
clinical practice. The study was planned and initiated as 
an 18-month randomized, controlled, semi-blinded exercise 
trial in a parallel group design with one exercise and one 
attention control group. The Institute of Medical Physics 
(IMP), University of Erlangen-Nürnberg (FAU), Germany 
as the responsible partner within the ACTLIFE consortium, 
implemented and conducted the study. The present RCT 
was approved by the Ethics Committee of the Friedrich- 
Alexander-Universität Erlangen-Nürnberg (number 
118_18b) and the Federal Bureau of Radiation Protection 
(BfS, number Z5 – 22,462/2 - 2018-055). ACTLIFE-RCT 
fully complies with the Helsinki Declaration.19 All the 
study participants gave their written informed consent 
after detailed information. The RCT was registered under 
ClinicalTrials.gov: NCT03959995. Although we report 
study results after 13 months of exercise (February 2019– 
March 2020), due to the COVID-19 induced lockdown in 
Bavaria, Germany on 20 March 2020, the data have to be 
considered as final study results.
Participants
The recruitment process of the ACTLIFE-RCT was 
reported previously. Briefly, using a pool of about 9600 
contact data records provided by the municipality, 2500 
women aged 48–60 years living independently in the area 
of Erlangen-Nürnberg, Germany were randomly selected 
and contacted by personalized letters that included the 
most relevant eligibility criteria (eg, menopausal status, 
exercise). A total of 332 women responded by phone or 
letter and were further assessed for eligibility by phone 
calls. Eligible women were then invited to bone densito-
metry and structured interviews to validate their inclusion. 
We included women with a) early-menopause status 
defined as 12–60 months amenorrhea, b) osteopenia or 
osteoporosis without fractures up to a BMD T-Score of 
−4 SD at the lumbar spine, femoral neck or total hip. 
Women with a higher fracture risk (ie, BMD T-Score >4 
SD) are entitled to pharmaceutic therapy according to 
German guidelines20 and therefore excluded from the 
study. Women who reported a) medication (ie, 
Glucocorticoids >5mg/d), conditions and diseases known 
to affect bone metabolism or contraindicate group exercise 
or tests; b) high impact or resistance exercise (>45 min/ 
week) during the last 5 years, ie, exercises with high 
ground reaction forces like “running”; c) secondary osteo-
porosis or osteoporotic fractures; d) acute or recent history 
of cancer (last 5 years); e) regular “high” alcohol con-
sumption (ie, ≥60 g/d on 5 days/week); f) potential una-
vailability for more than 6 weeks between January 2019 
and September 2020 (ie, during the study period) were 
excluded (Figure 1). In cases of doubt, the final decisions 
were made by the study physician. After detailed study 
information, 21 of the 75 eligible women quit the study. 
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Most attributed this to the mandatory randomized group 
allocation and the inability to join the preferred group. The 
54 remaining women eligible and willing to participate 
were randomly assigned to the groups (Figure 1).
Randomization Procedures
Using two strata, 54 participants were stratified for baseline 
lumbar spine BMD and randomly assigned to the EG (n=27) 
or the CG (n=27). Participants allocated themselves to the 
two groups by drawing lots from small opaque capsules 
(“kinder egg”, Ferrero, Italy) placed in a bowl. 
A researcher not involved in the present project prepared 
the lots and supervised the randomization procedure. Neither 
researchers nor participants knew the allocation beforehand 
(“allocation concealment”). After the randomization proce-
dure, the principal investigator (MH) enrolled participants 
and instructed them in detail about study specifications.
Blinding
Outcome assessors and test assistants who were unaware 
of the participants’ group status (EG or CG).
Study Procedure
ACTLIFE-RCT focused on the effects of exercise on 
menopausal risk factors and complaints with special 
regard to BMD. All participants were provided with 
Cholecalciferol (Vit-D) and Calcium (Ca) supplements in 
order to realize current recommended intake (ie, 800 IU/d 
Vit-D; 1000 mg/d Ca,20 details see below). Participants 
were asked to maintain their usual dietary intake during 
the study; further, all women were requested to maintain 




In summary, our exercise protocol was tailored to the 
complex risk factor profile of (early) postmenopausal 
women and used a multimodal approach. We placed parti-
cular emphasis on BMD at LS and hip with a mixture of 
weight-bearing exercise mainly involving aerobic dance 
with moderate to high ground reaction forces, jumping 
and resistance exercise. The latter was designed as single- 
set exercise training (HIT-RT) with high intensity and 
effort using intensifying strategies.21 The intervention 
was structured in blocks of 10–12 weeks of high- 
intensity/high effort exercise, interspersed with 4–5 
weeks of recreational exercise between each phase. 
During the 10–12 week phases, three supervised group 
sessions/week (s/w) with 8–10 participants/group were 
conducted in our lab (Mondays and Wednesday ≈40min) 
and a dedicated women’s gym that offered RT (Friday or 
Saturday ≈60 min) on devices, while during the recrea-
tional phase one supervised session in our lab was 
replaced by a video-guided individual home session of 
15 min involving exercises practiced during the joint ses-
sions. During the first four weeks of exercise, we focused 
on briefing, familiarization, learning of correct movements 
and lifting technique, body sensation and the use of the 
rate of perceived exertion approach.
Aerobic sequence. After 5 min of low-impact aerobic 
dance for warm-up, participants took part in 15 min of 
high impact aerobic dance with 6–10 varying movements 
of progressively increasing mechanical intensity (ground 
reaction forces: GRF: 2.0–3.0 body mass; ground reaction 
forces of different movements were determined in pre-
vious studies with comparable cohorts of early postmeno-
pausal women).17,22 In summary, 80–120 high impact 
movements were conducted during each aerobic dance 
session. After 4 weeks of moderate-intensity continuous 
exercise, we applied high-intensity interval training (HIIT) 
with varying cardiovascular exercise intensity. Once 
a week, 60 seconds of high-intensity phases (≈80–85% 
HRmax) were interspersed with 60 seconds of lower inten-
sity (≈65–70% HRmax) exercise, the second session 
Figure 1 Participant flow through the study.
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applied a corresponding 30s/30s exercise protocol. 
Exercise intensity was checked by regular analysis of the 
heart rate monitors provided to the participants. HRmax 
was determined by a stepwise treadmill test to a voluntary 
maximum, using steps of 3 min, speed increases of 1 km/h 
and 1% incline of the treadmill. Apart from high exercise 
intensity and proper movements, emphasis during the 
aerobic dance session was on enjoyment and interaction 
of the participants rather than complicated choreographies.
After 6 months, we introduced a dedicated jumping 
sequence. We applied a jumping course with 7 step boards 
of varying height that participants jumped over or on. This 
jump sequence was repeated 8 times with 20s of rest 
between each repetition. Step-boards were progressively 
elevated (from 20 to 36cm) over the course of the inter-
vention. Peak GRF for the deep jump from the highest step 
board averaged at about 4–4.5x body mass.
Dynamic resistance exercise training (DRT) can be 
considered a key component of our exercise protocol. 
Participants were provided with detailed training logs 
that prescribed exercises, number of repetitions (gym) or 
loading duration (circuit), movement velocity and absolute 
exercise intensity (or “effort”).
After the initial 4-week conditioning phase, we intro-
duced the periodized DRT approach and applied three 
(intensity-based) linearly periodized 4-week phases, with 
every fourth week as a recovery week with low effort. 
During the DRT sequence conducted in our lab, a single- 
set approach that addressed all the main muscle groups 
(calf rises, lunges, leg-press, half squat, (half) squats; back 
extension (roman chair), deadlifts; single side lateral rows, 
trapezius and latissimus pulldowns, bench dips, incline 
dumbbell bench press) was applied in a circuit mode. 
Correspondingly, we did not prescribe the number of 
reps but the duration of the loading cycles, which varied 
between 40s, 60s and 80s and the time under tension per 
repetition (TUT: 2s (concentric) – 1s (isometric) – 
2s (eccentric), = 2-1-2). We consistently applied 30s of 
rest between the exercises. Thus, the number of repetitions 
(reps) averaged between 8 (40s) and 16 reps (80s). 
Exercise intensity during the first 12-week block was pre-
scribed as repetition maximum minus 1–2 reps.23,24 
During the second 12-week (phase 2) high-intensity DRT 
period, we manipulated movement velocity. Applying 
a TUT that varied between explosive movement (except 
back extension and deadlift) – 1s (isometric) 1s/(iso-
metric) – 2s (eccentric) and 4s – 0s - 4s, the number of 
repetitions (reps) ranged between 5 and 20 reps 
per session. Similar to Phase 1, exercise intensity was 
prescribed using the repetition in reserve (RIR) approach 
of Zourdos et al,24 and the set endpoint definition of Steele 
et al,23 (nRM; repetition maximum minus 1–2 reps). After 
32 weeks of exercise (phase 3), we introduced the repeti-
tion maximum approach.23 Set endpoint was when trainees 
completed the final repetition possible, but if the next 
repetition was attempted, they would definitely achieve 
muscular failure (ie, inability to conduct the rep). 
Comparable to the previous training period movement 
velocity and the number of reps/loading cycle was flexibly 
manipulated; relative intensity varied from 60% 1 RM for 
20 reps (80s; 2-0-2) and 80% 1RM for 6 reps (30s; expl. – 
1s-3s). Of importance, sets conducted with explosive 
movements were consistently nRM sets. After 4 weeks 
of low effort exercise, in Phase 4 we introduced the drop- 
set approach, typical for HIT-RT. We manipulated the 
order of exercises within the circle to address either the 
same/related muscle groups (eg, lunges-leg press-half 
squat) or agonist and antagonist (eg, leg press-deadlift) in 
a row. Two or three exercises were included in a superset 
sequence. Intermitted by 5 weeks of low effort exercise, 
we conducted the present follow-up assessment and aimed 
to start with Phase 5 in March 2020. Phase 5 should focus 
on work to failure, simplified the inability to (properly) 
conduct the concentric phase of the current rep.23 
However, due to COVID-19 lockdown, we had to stop 
exercising and after 2 months of obligatory break we 
finally stopped the study initially designed for 18 months.
Apart from circuit training in our lab, participants 
trained on dedicated resistance training machines in 
a women’s gym once a week (Fridays or Saturdays). In 
general, the exercise training on devices was structured 
much the same way, the only difference being that the 
number of reps rather than the time of the loading cycle 
(circuit) was specified. Women completed a 15-minute 
warm-up on a cross-trainer (65–70% HRmax), before 
starting the DRT. The supervised single-set exercise 
approach of the gym training addressed 13–15 exercises 
(leg press, -extension, -curls, -adduction, -abduction, 
latissimus front pulleys, rowing, roman chair, trunk 
extension, -flexion, inverse fly, bench press, military 
press, lateral raises, shoulder/triceps press). Similar to 
the circuit training, we scheduled a linearly periodized 
exercise protocol with a varying number of repetitions, 
movement velocity, and varying intensity (nRM to RM; 
5–20 reps at nRM −1 rep corresponding to 65–82.5% 
1RM25) with a rest between the sets averaging 60 s–120 
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s. Relative peak intensity (eg, 4 reps to RM ≈85% 1RM) 
was slightly higher in the gym protocol. The same inten-
sifying strategies were otherwise applied.
During the 4–5 week low effort periods, one circuit 
session (see above), one 45 min session of stretching and 
floor exercises (see control group) and one video-guided 
home training session (see control group) of 15 min were 
conducted.
Control Group
The exercise in attention control group focused on stabi-
lity, flexibility and well-being, albeit with a strong empha-
sis on applying an exercise protocol that should not 
relevantly affect “bone”, “body composition” or “maxi-
mum strength/power”. During the 13-month intervention 
period, we completed 2 cycles of 12 weeks of supervised 
group exercises (45 min) intermitted by 12–14 weeks of 
non-supervised, video-guided home exercise (15 min).
The consistently supervised group training (8–10 parti-
cipants/group) session started with 15 minutes of walking/ 
marching exercise followed by 20 minutes of stretching and 
easy floor exercises and 10 minutes of cool down. Lower 
and upper calf, hamstring, thigh, gluteal, hip flexors, lower 
and upper back, abdominal, and pectoralis sites were exer-
cised with one set of stretching routines each with 30 s/ 
exercise of moderate intensity. Participants were asked not 
to exceed a pleasant feeling of tension. Predominately easy 
isometric floor exercises in a sitting, supine or prone position 
focused predominately on trunk muscle groups. Two sets 
each of 6–8 varying exercises/session with 10 s of moderate 
intensity (“5” on Borg CR 10)26 and 30 s of rest were 
conducted. During the 10 minutes of cool down, the instruc-
tor presented different “fantasy journeys” to encourage gen-
eral relaxation or body awareness.
During the non-supervised phases, participants were 
provided with training videos that summarized the joint 
training session. Fifteen minutes of stretching and iso-
metric exercises, which had been demonstrated during 
the supervised training period, were conducted during the 
home training session. The non-supervised training period 
finished immediately before the 13-month follow-up 
assessment.
Vitamin-D and Calcium Supplementation
All participants were requested to take two capsules of 
cholecalciferol (MYPROTEIN, Cheshire, UK) of 2500 IE/ 
d once a week (ie, 5000 IE/week) independently of their 
baseline 25OH D levels. We aimed to ensure a calcium 
intake of 1000 mg/d for all the participants.20 Dietary 
calcium intake was determined using dietary calcium 
questionnaires (Rheumaliga, Switzerland); to determine 
the dose of calcium provided via calcium carbonate cap-
sules (Sankt Bernhard, Bad Dietzenbach, Germany).
Compliance with the Exercise 
Intervention
Participant attendance was recorded by the instructor and 
verified by the gym’s chip card system. Adherence to the 
exercise protocol, particularly the application of proper exer-
cise intensity was checked by a) reviewing the training logs 
after each 12-week mesocycle and b) by the instructors that 
monitor the load/repetition proportion during the sessions.
Study Outcomes
Primary Study Outcome(s)
● Bone Mineral Density changes at the lumbar spine 
and hip as determined by Dual-Energy X-Ray 
Absorptiometry (DXA) from baseline to 13-month 
follow-up assessment.
Secondary Study Outcomes
● Soft lean body mass, and total and abdominal body 
fat changes as determined by DXA from baseline to 
13-month follow-up.
● Changes of cardiometabolic risk as determined by the 
metabolic syndrome27 Z-Score28 from baseline to 13- 
month FU.
● Changes of menopausal symptoms as determined by 
menopausal rating scale II29 from baseline to 13- 
month FU.
● Maximum dynamic hip/leg extension strength 
changes as determined by an isokinetic leg press 
from baseline to 13-month FU.
● Maximum jumping height as determined by a force 
plate from baseline to 13-month FU.
Changes of Trial Outcomes After Trial 
Commencement
Due to the COVID-19 lockdown in Bavaria, which 
included the closing of all sports and exercise facilities 
(17 March to 8 June 2020), we decided after 8 weeks of 
deconditioning to discontinue the study. We were unable to 
conduct the MRI assessment initially planned after 18 
months at the new 13-month endpoint.
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Assessments
High emphasis was placed on standardized testing and 
assessments. Participants were asked to avoid changes in 
dietary intake and physical activity prior to the tests. All 
the tests/assessments were conducted at the same time 
of day (±90 min), at the same location, using the same 
calibrated devices, but not always (ie, blood sampling, 
strength/power assessments) by the same test assistant.
Body height was determined using a Holtain stadi-
ometer (Crymych Dyfed., Great Britain), body mass was 
assessed using the scale function of the direct-segmental, 
multi-frequency Bio-Impedance-Analysis (DSM-BIA; 
InBody 770, Seoul, Korea). Total and regional body com-
position and areal BMD at the lumbar spine (LS) between 
L1-L4 vertebrae and total hip (TH) were assessed by DXA 
(QDR 4500a, Discovery-upgrade, Hologic Inc., Bedford, 
USA). Abdominal body fat was segmented between the 
lower end of the 12th thoracic vertebra and the upper end 
of the iliac crest. Segmentation of LS and TH area and 
regional body composition (ie, abdominal region, thigh 
region) was conducted using the “compare mode”, so 
that baseline area and placement of the baseline assess-
ment could be reproduced exactly during the FU 
assessments.
Blood was drawn from an antecubital vein after an 
overnight fast between 7:00 and 9:00 on a different day 
from the DXA, blood pressure or functional assessments. 
Serum samples were centrifuged for 20 min at 3000 RPM; 
glucose, total cholesterol, HDL and LDL cholesterol and 
triglycerides (Olympus Diagnostica GmbH, Hamburg, 
Germany) were immediately analyzed in the 
“Zentrallabor” of the Medical Department, FAU.
Immediately after 10 min of rest (during DXA assess-
ment), blood pressure (RR) was evaluated in a lying posi-
tion with an automatic oscillometric device (Bosco, Bosch, 
Jungingen, Germany). Subjects were requested to arrive at 
the assessment in a relaxed, non-fasting condition but 
having refrained from coffee or tea for at least 2 hours 
prior to testing. We calculated Mean Arterial Pressure 
(MAP) (diastolic RR + diastolic RR + systolic RR)/3.
We calculated the MetS-Z-Score using the 
International Diabetes Federation definition27 and applying 
the approach of Johnson et al,28 for the calculation. We 
calculated the MetS-Z-Score as: [(50 – HDL-cholesterol) 
/SD HDL-C] + [(triglycerides – 150)/SD TriGly] + 
[(Glucose – 100)/SD Glucose] + [(waist circumference – 
80)/SD WC] + [(MAP – 100)/SD MAP].
We used an isokinetic leg press (CON-TREX LP, 
Physiomed, Laipersdorf, Germany) to determine maxi-
mum isokinetic leg/hip extensor strength. We conducted 
the test in a sitting, slightly supine position, hip and chest 
fixed with straps. The participants’ feet were positioned on 
a flexible sliding footplate and also fixed with straps. The 
range of motion was 30° to 90° within the knee angle; 
velocity of the movement was 0.2 m/s. Emphasis was 
placed on the concentric part of the movement (ie, hip/ 
leg extension). After familiarization with the testing pro-
cedure, the women conducted five reps with maximum 
effort (“push as strongly as possible”). Two minutes of 
rest were specified between the two trials. The higher 
value of both trials was included in the data analysis.
We determined lower extremity power by 
a countermovement jump (CMJ) with hands on hips (ie, 
no arm swing) during the trial. We asked participants to 
“jump as high as possible” starting from an upright posi-
tion. Countermovement depth was not specified. We asked 
participants to maintain extension in the hip, knee, and 
ankle joints to prevent any additional flight time by bend-
ing their legs. Jumping height (present outcome) and 
power were determined by a force platform (KMP 
Newton GmbH, Stein, Germany). The jumping height 
was calculated automatically by the software provided by 
the manufacturer based on ground reaction forces.
All participants had to complete a standardized base-
line questionnaire17 that asked for a) demographic para-
meters; b) diseases, physical limitations and 
pharmacologic therapy under special consideration of 
osteoporosis risk and ability to frequently conduct inten-
sive exercise; c) dietary supplements; d) pain frequency 
and severity at the lumbar spine region; e) lifestyle, with 
high emphasis placed on physical activity and exercise;30 
and f) menopausal complaints as per the Menopause 
Rating Scale (MRS II) provided by Hauser et al.29,31 
After 7 and 13 months, all participants had to complete 
a follow-up (FU) questionnaire that particularly focused 
on changes in parameters (ie, pharmacologic therapy, dis-
eases, operations, lifestyle, diet, exercise) that might have 
affected the present study outcomes. Strong emphasis was 
placed on checking questionnaires for consistency, com-
pleteness and accuracy together with the participants.
Four-day diet records were completed at baseline and after 
7- and 13-month FU. We briefed and instructed participants in 
detail on how to keep the diet records (Freiburger Nutrition 
Record (nutri-science, Hausach, Germany)). We asked parti-
cipants to protocol 3 weekdays and one weekend day 
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representative for their nutritional habits. Diet records were 
carefully analyzed consistently by the same researcher. In 
cases of unlikely results (eg, energy intake <1000 kcal/d or 
>3500 kcal/d) the results were discussed with the participants. 
In all cases, the women were requested to provide another diet 
record based on more representative days.
Sample Size Calculation
The sample size calculation was based on the primary 
study outcome “BMD changes at the LS” after 18 months. 
We assumed an effect (Δ-EG vs Δ-CG) on BMD-LS of 2.0 
±2.5% as determined in other exercise studies with early 
postmenopausal women in our lab22,32 and applied ainde-
pendent t-test based sample size calculation. In summary, 
the sample size required to generate 80% power (1-β) and 
alpha=0.05 was 25 participants per group. We included 27 
participants to allow for drop-outs within an additional 
per-protocol analysis for the primary study outcome.
Statistical Analysis
As prescribed for an RCT, we conducted an intention to treat 
(ITT) analysis that included all participants assigned to the 
two study arms (EG vs CG) at baseline. Additionally, a per- 
protocol analysis was performed for the primary study out-
come that only included participants with complete datasets 
independently of compliance with the exercise protocol or 
potentially confounding factors. Using R statistics 
software,33 we calculated multiple imputations (ITT) in 
combination with Amelia II.34 The full data set was used 
for multiple imputations with imputation being repeated 100 
times. Imputation diagnostic plots provided by Amelia II 
indicated that imputation for primary and secondary out-
comes worked well. Normal distribution of the study end-
points was checked by statistical (Shapiro–Wilks) and 
graphical (qq-plots) procedures. Within-group changes 
were tested for by dependent t-tests. Pairwise t-test compar-
isons (EG vs CG) with pooled SD adjusted for baseline 
values were applied to test for group differences. 
Alternatively, a repeated measures ANOVA (group by time 
interaction) was calculated within the per-protocol analysis. 
We applied 2-tailed tests; significance was accepted at 
p <0.05. Standardized mean difference (SMD) was calcu-
lated according to Cohen (Cohen’s d).35
Results
Baseline characteristics of the ACTLIFE-RCT study are 
shown displayed in Table 1. Of note, dietary protein intake 
was high in both groups. Albeit non-significant, 25 OHD 
concentration and alcohol intake varied considerably 
between the groups. Dietary calcium intake was similar 
(low) in both groups (Table 1); however in contrast to 
cholecalciferol supplementation (800–1000 IE/d; n=8 in 
EG and CG, respectively), no women used calcium supple-
ments before the study start. Nevertheless, baseline Vit-D 
levels were on average below recent recommendations.19 
Further, dietary protein intake was quite high in both groups. 
As intended, exercise volume was low in both groups and 
focused predominately on aerobic exercise.
Six women in the EG and seven women of the CG were 
lost to a 13-month follow-up. Three women in each group quit 
the intervention (Figure 1). Four in the CG and three women 
in the EG were unable to visit the 13-month follow-up assess-
ment, which had a very close window of only 3 days due to 
the rapid and restrictive COVID-19 lockdown procedure in 
Bavaria. Reasons for withdrawal are listed in Figure 1.
On average, participants in the EG completed 129±21 
of 164 possible sessions (79±12%). Of note, the session in 
our lab was more popular than the gym sessions (83% vs 
75%). The attendance rate of the CG for the two super-
vised and two 12-week non-supervised exercise training 
periods averaged 78±14%. Participants reported that they 
consistently adhered to the exercise protocol; however, 
monitoring of “effort” by checking the relationship of 
reps and load selected to realize RM indicated that 
Table 1 Baseline Characteristics of the ACTLIFE-RCT Study




Age [years] 54.5 ± 1.6 53.6 ± 2.0
Body height [cm] 164.5 ± 8.2 164.2 ± 6.0
Body mass [kg] 67.4 ± 14.6 64.0 ± 9.6
BMI [Weight/(Height*Height)] 24.9 ± 4.8 23.7 ± 3.4
Calcium intake [mg/d] 642 ± 265 645 ± 252
Vit-D level (25-OHD) [ng/mL] 21.6 ± 10.8 27.8 ± 11.7
Years after menopause [yr] 3.5 ± 1.1 3.7 ± 1.0
Exercise volume [min/week] 45.6 ± 38.4 63.7 ± 47.5
Waist circumference [cm] 91.1 ± 9.9 87.8 ± 8.6
Energy intakea [kcal/d] 2067 ± 355 2009 ± 444
Protein intake [g/kg/body mass/d] 1.20±0.21 1.18±0.27
Fat intake [g/d] 86 ± 24 84 ± 21
Alcohol intakea [g/d] 5.53 ± 6.39 2.63 ± 4.06
Smokers [%] 11 7
Ovariectomy <50 years [n] 0 1b
Family dispositionc [n] 9 7
Notes: aAs determined by a 4-day dietary protocol, see methods; bAt age 47 years; 
cFragility fractures or verified osteoporosis in close relatives (parents, aunts, uncles, 
grandparents).
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women did not always follow the RM specification. This is 
particularly the case for the first high-intensity phase.
Primary and Secondary Study Outcomes
LS-BMD, the primary study outcome, was maintained in the 
EG (p=0.517) and decreased significantly in the CG (p=0.015) 
(Table 2). LS-BMD changes differ significantly between the 
two groups (p=0.026; SMD=0.62; Table 2). In parallel, BMD 
at the total hip decreased significantly in the CG (p=0.023) and 
was maintained in the EG (p=0.756). Corresponding differ-
ences between the groups were non-significant (p=0.129, 
SMD=0.38; Table 2). Thus, we reject our primary hypothesis 
that the EG demonstrated greater effects on BMD at the LS 
and total hip compared with an attention CG.
LBM increased in the EG (p<0.013) and was main-
tained in the CG (p=0.127). Differences between the 
group changes were significant (p<0.026, SMD: 0.63; 
Table 3).
Total body fat percentage decreased in the EG 
(p<0.001) and was maintained in the CG (p=0.930). 
Changes between EG and CG for total body fat percentage 
were significantly different (p<0.002; SMD: 0.93; Table 
3). In parallel, abdominal body fat percentage was main-
tained in the CG (p=0.835) but decreased (p=0.002) in the 
EG Changes among the EG and CG varied between the 
two groups (p=0.011, SMD: 0.72; Table 3).
The MetS-Z-Score was maintained in the EG (p=0.804) 
and worsened (p=0.041) in the CG. However, pre- to post- 
intervention changes in MetS-Z-score did not differ between 
EG vs CG (Table 4). Favorable effects of exercise were 
determined for waist circumference (EG: −2.9±3.9 cm vs 
CG: −0.4±3.6 cm, p=0.010; SMD: 0.75) and MAP (EG: 1.7 
Table 2 Baseline Data and Changes of BMD at LS and TH in the CG and EG and Corresponding Between Group Differences. *P<0.05
CG MV±SD EG MV±SD Difference MV (95% CI) p-value
Bone Mineral Density (BMD) at the lumbar spine [mg/cm2]
Baseline 0.904 ± 0.097 0.873 ± 0.130 ———— 0.314
Changes −.009 ± 0.018* 0.002 ± 0.018 0.011 (0.001 to 0.021) 0.027
Bone Mineral Density (BMD) at the total hip [[mg/cm2]
Baseline 0.826 ± 0.056 0.804 ± 0.099 ———– 0.337
Changes −.009 ± 0.020* −.001 ± 0.016 0.008 (−.002 to 0.017) 0.129
Table 3 Baseline Data and Changes of Anthropometric Parameters in the CG and EG and Corresponding Between Group 
Differences. *P<0.05; **P<0.01; ***P<0.001
CG MV±SD EG MV±SD Difference MV (95% CI) p-value
(Soft) Lean Body Mass (LBM)[kg]
Baseline 41.34 ± 6.43 40.39 ± 4.78 ———— 0.544
Changes −0.37 ± 1.34 0.39 ± 1.08* 0.76 (0.10 to 1.43) 0.026
Total Body Fat Percentage [%]
Baseline 34.2 ± 6.9 34.0 ± 5.0 ———– 0.866
Changes −0.02 ± 1.55 −1.44 ± 1.49*** 1.42 (0.54 to 2.29) 0.002
Abdominal Body Fat Percentage [%]
Baseline 28.6 ± 9.2 28.5 ± 7.0 ———— 0.972
Changes 0.08 ± 2.02 −1.50 ± 2.33** 1.58 (0.38 to 2.78) 0.011
Table 4 Baseline Data and Changes of the Metabolic Syndrome Z-Score in the CG and EG and Corresponding Between Group 
Differences
CG MV±SD EG MV±SD Difference MV (95% CI) p-value
Metabolic Syndrome Z-Score [Index]
Baseline −4.15 ± 3.99 −5.51 ± 2.43 ———— 0.143
Changes 0.77 ± 2.07 0.08 ± 1.29 0.69 (−0.20 to 1.65) 0.149
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±8.5 vs CG: −2.8±6.0 mmHg, p=0.030 SMD: 0.61) only, 
while changes in fasting blood glucose (EG: 4.4±8.2 vs CG: 
4.2±8.3 mg/dl, p=0.933, SMD: 0.02), triglycerides (EG: 
12.2±40.6 vs CG: 11.1±29.3 mg/dl, p=0.907, SMD: 0.03) 
and HDL-C (EG: 1.0±8.5 vs CG: 4.1±8.6 mg/dl, p=0.187, 
SMD: 0.36) did not differ between EG and CG.
Menopausal symptoms as determined by the MRS II 
(Table 5) improved in both groups; however, the 
changes from pre- to post-intervention were only sig-
nificant in the EG (EG: p=0.002 vs CG: p=0.891). 
Further, significant between-group differences for MRS 
were observed (p=0.029; SMD: 0.59). However, 
although changes of all the subscales (“dimensions”) 
of the MRS II, ie, somato-vegetative, psychological, 
and urogenital complexes, were more favorable in the 
EG, significant differences between EG and CG (p≥.10) 
were not observed.
Finally, maximum leg press (p<0.001) and jumping 
performance (p<0.001) increased in the EG and improved 
only slightly (strength: p=0.314; power: p=0.197) in the 
CG (Table 6). Differences between the groups were sig-
nificant for maximum hip/leg extension strength (p<0.001; 
SMD: 2.33) and lower extremity power (p=0.001; 
SMD: 1.66).
Thus, apart from hypothesis (d) (ie, effects on cardio-
metabolic risk), all the hypotheses addressed were con-
firmed. In each case, the per-protocol analysis confirmed 
the result of the ITT analysis.
We did not observe changes or between-groups differ-
ences for dietary intake parameters (ie, energy, carbohy-
drate, fat, protein, alcohol intake), lifestyle including 
physical activity/exercise or pharmacologic therapy that 
might have affected our result. In parallel, no changes in 
diseases with impact on our study outcome or absence >2 
weeks from exercise were reported. 25 OHD serum con-
centration improved significantly and comparably (EG: 9.3 
±9.1 vs CG: 9.1±10.5 ng/mL) in both groups.
Discussion
In this study, we aimed to determine the effect of 
a multipurpose exercise program on menopausal risk fac-
tors and complaints in early postmenopausal women with 
osteopenia and osteoporosis.36 Our training protocol was 
based on international recommendations,37–39 meta- 
analyses16 and a review of “European experience” (limited 
to ACTLIFE partner countries) on secondary and tertiary 
osteoporosis prevention by means of exercise. However, in 
order to generate a multipurpose exercise protocol, we 
included types of exercise (eg, endurance exercise) that 
also focus on other risk factors related to the menopausal 
transition. Despite the sophisticated exercise protocol, 
BMD at the total hip showed no change as a result of 
the intervention. By comparison, Watson et al,40 who used 
a much more condensed (2x 30 min/w.) high-intensity 
resistance and impact exercise protocol reported a much 
higher effect on BMD at LS (EG: 2.9±2.8% vs CG: −1.2 
Table 5 Baseline Data and Changes of Menopausal Symptoms According to MRS II and Low Back Frequency in the CG and EG and 
Corresponding Between Group Differences. **P<0.01
CG MV ± SD EG MV ± SD Difference MV (95% CI) p-value
Menopause Rating Scale II [Score Points]a
Baseline 1.20 ± 0.52 1.06 ± 0.64 ————– 0.365
Changes −0.01 ± 0.54 −0.32 ± 0.51** −0.31 (0.03 to 0.59) 0.029
Notes: aScale from 1 (no complaints) to 5 (very serious complaints).
Table 6 Baseline Data and Changes of Maximum Hip/Leg Extension Strength and Maximum Jumping Height in the CG and EG and 
Corresponding Between Group Differences. *** P<0.001
CG MV ± SD EG MV ± SD Difference MV (95% CI) p-value
Maximum hip/leg extension strength (leg press) [N]
Baseline 2056 ± 576 2073± 429 ————– 0.901
Changes 46 ± 187 607 ± 285 *** 561 (427 to 694) <0.001
Maximum jumping height (counter movement jump) [cm]
Baseline 19.1 ± 3.2 19.4 ± 3.7 ————– 0.807
Changes 0.55 ± 1.82 4.10 ± 2.41 *** 3.56 (2.38 to 4.72) <0.001
Clinical Interventions in Aging 2021:16                                                                                     submit your manuscript | www.dovepress.com                                                                                                                                                                                                                       
DovePress                                                                                                                          
91

































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
±2.8%, p<0.001) and FN (0.3±2.6% vs −1.9±2.6%, 
p=0.004) in their albeit older (65±5yr) cohort of women 
with osteoporosis. One may argue that the early-postme-
nopausal status of our participants might have contributed 
to this difference; however, a recent meta-analysis-
16 indicates a somewhat higher (. . . but non-significant) 
plausible explanation for the rather low effects on BMD 
might be the careful gradual progression of the exercise 
intensity in the present intervention. This gradual progres-
sion might not have reached a threshold for bone adaption 
until 5-6 months. With the remaining 7 months of expo-
sure to “effective” exercise too short to elicit the full 
amount of mineralized bone,41 assuming bone adaptation 
in adults is triggered predominately by remodeling.42,43 
Although the loading intensity triggered by HIT-DRT (up 
to ≈80% 1RM; corresponding to 5 reps with nRM) and 
high impact aerobic dance (up to GRF 3.0 body mass) 
applied after the short conditioning should have stimulated 
bone metabolism in predominately untrained females, the 
aforementioned highly effective 8-month study of 
Watson40 suggests otherwise. Finally, the “exercise- 
induced” effects in the attention control group may have 
confounded our result. However, one session of 45 or 15 
min, respectively, of easy floor exercises, flexibility and 
wellbeing should not relevantly affect BMD changes 
(Table 2) in the CG.44,45 Indeed, LS and TH-BMD devel-
opments of the CG were inconspicuous considering the 
average menopausal age (3.7 ± 1.0 yrs) in this group. In 
this context, it should be considered as a study limitation 
that we applied a rather broad window of 5 years for the 
“early postmenopause”. However, the most prominent 
bone decline might occur during the 3-year phase of the 
transmenopause, ie, one year before and two years after 
the final menstrual period.36
Apart from bone, LBM and body fat are also nega-
tively impacted by the menopausal transition.46,47 We 
found significant positive effects on both parameters. 
However, the effect on LBM was of a much smaller 
magnitude (0.76; 95% CI: 0.10 to 1.43 kg) than described 
in provided by a recent meta-analysis48 of younger (≤50 
years) women (1.45, 0.4–3.3 kg). Nevertheless, applying 
a similar exercise protocol  (EG: 3x 45–60 min/week, 
intense RT and high impact exercise for 12 months vs 
CG: low intensity exercise) in our earlier TRACE study 
on early postmenopausal (1–3 years post) women18,22 
revealed comparable results (0.54, 0.13 to 0.94 kg). We 
observed an ongoing LBM effect with a ≈50% higher 
LBM effect after 13 months compared with 7-month FU 
(0.52, 0.17–0.88 kg). Effects on total and abdominal body 
fat were high (SMD: 0.72 and 0.92). Total body mass 
decreased significantly by about −4% (or −1.15±1.23 kg) 
in the EG and was maintained in the CG. A parallel, 
slightly less prominent development was observed for 
abdominal body fat percentage (Table 3). In general, aero-
bic exercise (AE) is considered more effective for decreas-
ing body fat compared with RT.49 However, the TRACE 
study,18,22 which applied a ≈50% higher AE volume (with 
similar exercise intensity up to 80–85% HFmax) compared 
to ACTLIFE, was unable to demonstrate effects on total 
and abdominal body fat mass (p≥.703, SMD<0.2). Of 
note, unlike LBM, total and abdominal body fat did not 
decrease after 7 months. This is surprising, since the 
literature attributes a considerable proportion of fat reduc-
tion to increases in resting metabolic rate induced by 
muscle mass.50,51 ACTLIFE-RCT did not determine sig-
nificant effects on the MetS-Z-Score (Table 4). 
Considering the positive effects on body composition and 
their recognized association to cardiometabolic risk 
factors52–54 expectations of positive effects on MetS- 
Z-Score were justified. Few exercise studies have used 
the MetS-Z as a study outcome, even fewer focus on 
mixed aerobic/resistance type or dedicated resistance- 
type exercise.55–63 While Bateman et al55 and Earnest et -
al58 did not report positive effects of a 4- or 9-month DRT 
in people with diabetes mellitus type II or overweight, 
sedentary people, other studies that applied 3–4 months 
of RT56,60–62 or mixed AE/RT protocol57,59 have verified 
significant positive effects on the MetS-Z-Score in 
male60,61 and among predominately postmenopausal 
female cohorts.56,57,59,62 The results largely reflect our 
4-month study results, even though effort (RM) and inten-
sity (up to 85% 1RM) of the exercise protocol were 
progressively increased.
We determined significant positive effects on meno-
pausal symptoms as determined by the MRS II scale.29 
However, we did not observe significant exercise effects in 
the three underlying MRS II components, ie, the somato- 
vegetative, psychological and urogenital dimensions. 
Previous studies reported positive exercise effects on psy-
chological factors64,65 and conflicting effects on vasomotor 
symptoms.66,67 This inconsistency in findings may be due 
to which MRS II components were included under 
“somato-vegetative dimension”.
Improvements in maximum hip/leg extensor strength 
and power (ie, maximum jumping height) averaged 27% 
(95%-CI: 19–36%) and 18% (95%-CI: 12 to 23%) from 
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the 8-month to the 13-month FU (p<0.05) in the EG 
indicate the effectiveness of our progressive training pro-
gram. Nevertheless, maximum strength changes were 
lower compared with other DRT trials in comparable 
female cohorts (30–85%).68–73 It is likely that this differ-
ence is due to the high baseline values in our cohort and 
slight improvements in the attention CG.
Due to the unintended termination of the study, some 
features and limitations of ACTLIFE-RCT have to be 
addressed. 1) The intended 18-month duration meant that 
we progressed gradually placing emphasis to a stepwise 
progression of exercise intensity/effort. However, the pre-
mature study termination led to the most intense (. . . and 
speculative “effective”) part of the protocol, ie, the last 6 
months, being truncated. Although when applying 
a strictly progressive protocol, one may argue that the 
majority of the physiological changes occurred during 
the first year,74 due to the nature of the remodeling 
cycle41 this may be less relevant for changes in BMD.
2) Due to the rapid closing of training and assessment 
facilities combined with the partial lock-down in Bavaria, 
we were forced to conduct our retests within three days (ie, 
Friday to Sunday), moreover with only 1 day advance 
notice. Due to this narrow window, seven participants were 
unable to join the tests. Although we applied ITT with the 
imputation of missing values and thus reached the calculated 
sample size of 25 participants per group, there is some 
evidence that we lost power compared with the calculation 
of a full dataset.75 3) Unlike pharmaceutic agents, exercise is 
a comprehensive tool which, if properly designed and 
applied, might positively address a large variety of biome-
dical variables. Thus, it is challenging to design and evaluate 
exercise protocols that aimed to address several aims impor-
tant for health and performance. Due to necessary compro-
mises and the need76,77 for time-effective training protocols, 
some parameters might not be optimally addressed. As 
shown by corresponding systematic reviews/meta-analysis, 
this approach results in lower overall effects; furthermore, 
the statistical procedures for handling multiplicity are diffi-
cult and debatable. 4) We introduced an active (attention) 
control group to give women in the CG an opportunity to 
exercise and so, without being too apparent, prevent those 
women from doing uncontrolled exercise with potentially 
more bone-specific effects. Considering that a waiting con-
trol group is not an option for an 18-month study, we opted 
for full communication of pros and cons of both groups, 
which can be considered as the reason why 21 women 
refused to be randomly assigned to the groups. Despite the 
low-intensity and low volume exercise protocol of the CG, 
considering the widely untrained status of our women, the 
exercise protocol may have affected some of the study end-
points addressed. Thus, we speculate that some changes 
between groups (eg, performance parameters, menopausal 
complaint) might be less pronounced compared to an 
approach with an “inactive” CG. 5) Baseline Vitamin 
D levels of both groups were below the recommended con-
centration but significantly improved after 13 months of 
supplementation. As studies have shown a positive effect 
of vitamin D supplementation on bone density,78 there is 
some evidence that Vit-D supplementation might have con-
tributed to our result.
Finally, it is difficult to endorse an exercise protocol 
that had to be terminated after 13 of the planned 18 
months and might therefore not have fully generated its 
potential effect – particularly on BMD. The advantages of 
the exercise protocol are its attractiveness, feasibility and 
safety. In summary, however, we have added further evi-
dence that a multipurpose exercise program positively 
affects a multitude of risk factors and complaints related 
to the menopausal transition or increasing age.
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